Adenosine A2A receptors in Parkinson’s disease treatment (original) (raw)
Related papers
Dopamine agonists and Parkinson's disease
Clinical Neurology and Neurosurgery, 1984
Drug treatment of Parkinson’s disease
Biochemical Pharmacology, 2000
Current Medicinal Chemistry, 2011
Adenosine: a prototherapeutic concept in neurodegeneration
1995
Therapeutic Potentials of Adenosine Receptors: The State of The Art
Current Pharmaceutical Design, 2019
Emerging Therapies in the Pharmacological Treatment of Parkinson???s Disease
Drugs, 2002
Potential of Adenosine-System-Based Therapies in the Treatment of Neuroimmune Disorders
2012
Ligand-Dependent Activation and Deactivation of the Human Adenosine A2A Receptor
Journal of the American Chemical Society, 2013
Annals of Medicine and Surgery, 2023
Targeting adenosine A 2A receptors in Parkinson's disease
Trends in Neurosciences, 2006
Ligand-Dependent Activation and Deactivation of the Human Adenosine A2A Receptor
Journal of the American Chemical Society, 2013
An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets, 2011
Adenosine Receptor Alterations in Nervous Pointer Dogs
Clinical Neuropharmacology, 1987
Increased adenosine deaminase serum activity
Revista Latinoamericana …, 2010
Carme Lluís, Josefa Mallol, Enric I. Canela
Biochemical Journal, 2011
Consequences of eliminating adenosine A1 receptors in mice
2003
Adenosine A2Areceptor antagonist treatment of Parkinson’s disease
Neurology, 2003
New therapies for the treatment of Parkinson's disease: Adenosine A2A receptor antagonists
Life Sciences, 2005
Supplement 4: Canadian Guidelines on Parkinson's Disease
The Canadian Journal of Neurological Sciences, 2012
The Journal of the American Dental Association, 2009
European Neurology, 2012
Hyperresponsiveness to adenosine in sensitized Wistar rats over-expressing A1 receptor
European Journal of Pharmacology, 2012
Neuropharmacology, 2011
Experimental models of Parkinson's disease
Nature Reviews Neuroscience, 2001
Treatment of Parkinson's disease with NADH
Acta Neurologica Scandinavica, 2009
Cortical inhibition in Parkinson's disease
Brain, 1996
Annals of the New …, 1997
The FASEB Journal, 2010
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
Pharmacology & Therapeutics, 2011
Cell Based Therapies in Parkinson’s Disease
Annals Of Neurosciences, 2011
Middle East Journal of Internal Medicine, 2020
Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
Neurology, 2011
Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
CNS Neuroscience & Therapeutics, 2010
Recent advances in cell-based therapy for Parkinson disease
Neurosurgical FOCUS, 2008
Caffeine and Progression of Parkinson Disease
Clinical Neuropharmacology, 2015